SuryaPrakashBhattMDMSPH

Pulmonology • Birmingham, AL

Asthma & COPD, Pulmonary Rehabilitation

Professor of Medicine, University of Alabama at Birmingham

Join to view full profile

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhatt's full profile

Already have an account?

Office
2000 6th Avenue South
Birmingham, AL 35233
Phone+1 205-934-5555

Summary

Medical Director, Pulmonary Function and Exercise Physiology Lab
Medical Director, Pulmonary Rehabilitation/Telehealth Pulmonary Rehabilitation
Director, UAB Lung Imaging Lab

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
St Luke's University HospitalResidency, Internal Medicine, 2006 - 2009
Mysore Medical CollegeClass of 2001

Certifications & Licensure

AL State Medical License 2012 - 2025
SC State Medical License 2017 - 2021
NC State Medical License 2017 - 2020
IA State Medical License 2008 - 2013
PA State Medical License 2006 - 2009
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Smart Telehealth Exercise Intervention to Reduce COPD Readmissions Start of enrollment: 2016 Jul 14
Completed
Not Applicable
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD Start of enrollment: 2013 Nov 25
Completed
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2019 Sep 25
Withdrawn
Phase 4
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Start of enrollment: 2020 Feb 11
Recruiting
Phase 4
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease Start of enrollment: 2022 Jun 28
Recruiting
Not Applicable
Roles: Principal Investigator
Evaluation of the Safety and Efficacy of TLD in Patients With COPD Start of enrollment: 2019 May 23
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry.
Spyridon Fortis, Matthew Strand, Surya P Bhatt, Patrick Ten Eyck, Linder Wendt
American Journal of Respiratory and Critical Care Medicine. 2025-02-13
Novel risk loci encompassing genes influencing STAT3, GPCR, and oxidative stress signaling are associated with co-morbid GERD and COPD.
Ava C Wilson, Alison Rocco, Joe Chiles, Vinodh Srinivasasainagendra, Wassim Labaki
Plos Genetics. 2025-02-01
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel
The Lancet. Respiratory Medicine. 2025-01-31

Press Mentions

Dupilumab Improves Quality of Life for COPD PatientsOctober 10th, 2024
Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
Join now to see all